Aptamers as a therapeutic tool to prevent protein aggregation in neurodegenerative disease
US11814625B2 · kind B2 · utility
0Cited by
1References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 22, 2018 |
| Grant date | Nov 14, 2023 |
| Priority date | — |
| Expiry date | Feb 14, 2040 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/2835
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure relates generally to the selection of DNA aptamers that prevent aggregation, or fibrilization of alpha-synuclein protein. The aptamers described herein are of use as a therapeutic tool to prevent protein aggregation in neurodegenerative disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.